FIELD: pharmaceutics.
SUBSTANCE: invention relates to method of inhibiting leucocidin ED toxicity of Staphylococcus aureus in individual. Described method involves: selection of individual infected with S. aureus, and introduction of CCR5 antagonist to subject selected in effective amount for inhibiting cytotoxicity of leucocidin ED of S. aureus in individual.
EFFECT: invention can be used for prevention and treatment of Staphylococcus aureus infection.
5 cl, 6 dwg, 2 tbl, 6 ex
| Title |
Year |
Author |
Number |
| METHODS OF TREATMENT AND PREVENTION OF STAFILOCOCCA INFECTIONS OF GOLDEN AND RELATED DISTURBANCES |
2012 |
- Torres Viktor Dzh.
- Alonso Frensis
|
RU2635462C2 |
| STAPHYLOCOCCUS AUREUS LEUKOCIDINS, THERAPEUTIC COMPOSITIONS AND THEIR APPLICATION |
2011 |
- Torres, Victor, J.
- Dumont, Ashley, L.
|
RU2677140C1 |
| STAPHYLOCOCCUS AUREUS LEUKOCIDINS, THERAPEUTIC COMPOSITIONS AND THEIR USE |
2018 |
- Torres Viktor Dzh.
- Dyumon Eshli L.
|
RU2795545C2 |
| STAPHYLOCOCCUS AUREUS LEUKOCIDINS, THERAPEUTIC COMPOSITIONS AND THEIR APPLICATION |
2011 |
- Torres Viktor Dzh.
- Dyumon Eshli L.
|
RU2644237C2 |
| POLYPEPTIDE ABLE TO BLOCK CELL SURFACE RECEPTOR CCR5 AND/OR TO INDUCE CCR5 INTERNALISATION AND/OR INHIBITORY REGULATION IN TARGET CELL, NUCLEIC ACID CODING IT, HOST CELL, USE (VERSION), PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING OR PREVENTING HIV INFECTION IN PATIENT (VERSIONS) |
2007 |
|
RU2461567C2 |
| ANTIBODIES AGAINST STAPHYLOCOCCUS AUREUS LEUKOTOXINS |
2019 |
- Tkaczyk, Christine
- Sellman, Bret
- Du, Qun
- Damschroder, Melissa
- Corti, Davide
- Minola, Andrea
|
RU2805969C2 |
| PEPTIDES WITH ANTAGONISTIC ACTIVITIES AGAINST NATURAL CXCR4 |
2014 |
- Forssmann Volf-Georg
- Kirkhkhoff Frank
- Myunkh Yan
- Shtendker Ludger
|
RU2671708C2 |
| COMBINATIONS OF ANTIBODIES TO STAPHYLOCOCCUS AUREUS |
2019 |
- Tkaczyk, Christine
- Sellman, Bret
- Du, Qun
- Damschroder, Melissa
- Cohen, Taylor
|
RU2804815C2 |
| COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF INFECTIONS CAUSED BY STAPHYLOCOCCUS AUREUS |
2015 |
|
RU2636780C1 |
| POLYPEPTIDES FOR TREATING STRESS SYNDROMES, IMMUNE RESPONSE AND STROKE |
2019 |
|
RU2824567C2 |
